Get to Know Alys Pharmaceuticals, Inc.
Alys Pharmaceuticals, Inc. is coming out of the gate strong with $100M financing from Medicxi to advance its immuno-dermatology focused pipeline. Alys combines six asset-centric Medicxi companies including Al Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics. Co-founded by Medicxi and several dermatology and scientific experts, including TDD Editorial Advisory Board member John […]